|
Market Closed -
Bombay S.E.
06:02:27 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 520.00 INR | +3.71% |
|
+1.12% | +18.59% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
| Market Cap | 1.86B 19.51M 17.47M 16.12M 14.59M 27.28M 27.72M 192M 76.73M 972M 73.21M 71.65M 3.08B | P/E 2025 |
10.4x | P/E 2026 | 8.08x |
|---|---|---|---|---|---|
| Enterprise Value | 1.59B 16.74M 14.99M 13.83M 12.52M 23.41M 23.78M 165M 65.84M 834M 62.82M 61.48M 2.64B | EV / Sales 2025 |
1.94x | EV / Sales 2026 | 1.23x |
| Free-Float |
19.97% | Yield 2025 |
0.21% | Yield 2026 | 0.54% |
| 1 day | +3.71% | ||
| 1 week | +1.12% | ||
| Current month | -8.46% | ||
| 1 month | -4.81% | ||
| 3 months | -9.84% | ||
| 6 months | +23.74% | ||
| Current year | +18.59% |
| 1 week | 475.7 |  | 536 |
| 1 month | 475.7 | | 638.7 |
| Current year | 360 | | 679 |
| 1 year | 360 | | 679 |
| 3 years | 275.1 | | 999 |
| 5 years | 217 | | 999 |
| 10 years | 81.2 | | 1,190 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 2017-05-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 2017-05-25 | |
| Director/Board Member | 49 | 2017-05-25 | |
Saurabh Shah
BRD | Director/Board Member | 40 | 2019-05-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.71% | +1.12% | +7.06% | +80.18% | 18.81M | |
| +6.81% | +5.02% | +68.68% | +142.58% | 1,148B | |
| +1.33% | +2.97% | +47.67% | +87.41% | 652B | |
| +1.65% | +1.71% | +28.84% | +104.43% | 505B | |
| +0.73% | +2.45% | +54.26% | +66.47% | 384B | |
| +4.21% | -0.57% | +69.09% | +42.58% | 348B | |
| +2.38% | +2.65% | +34.31% | +56.33% | 294B | |
| +2.26% | +0.55% | +3.92% | +27.74% | 264B | |
| +1.96% | +3.14% | +58.11% | +75.28% | 244B | |
| +4.06% | +4.88% | +39.12% | +111.98% | 197B | |
| Average | +2.89% | +1.00% | +41.11% | +79.50% | 403.72B | |
| Weighted average by Cap. | +3.41% | +1.50% | +50.15% | +93.69% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.15B 12.08M 10.82M 9.98M 9.03M 16.89M 17.16M 119M 47.5M 602M 45.32M 44.36M 1.91B | 859M 9.02M 8.08M 7.45M 6.75M 12.61M 12.82M 88.93M 35.48M 450M 33.85M 33.13M 1.42B |
| Net income | 242M 2.54M 2.27M 2.1M 1.9M 3.55M 3.6M 25.01M 9.98M 126M 9.52M 9.32M 400M | 164M 1.72M 1.54M 1.42M 1.29M 2.41M 2.44M 16.96M 6.77M 85.73M 6.46M 6.32M 272M |
| Net Debt | -274M -2.88M -2.58M -2.38M -2.15M -4.02M -4.09M -28.36M -11.31M -143M -10.79M -10.56M -454M | -264M -2.77M -2.48M -2.29M -2.07M -3.87M -3.94M -27.3M -10.89M -138M -10.39M -10.17M -437M |
Employees
149
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | ₹520.00 | +3.71% | 743 |
| 26-10-28 | ₹501.40 | +2.09% | 112 |
| 26-10-27 | ₹491.15 | -1.75% | 406 |
| 26-10-26 | ₹499.90 | +1.17% | 522 |
| 26-10-23 | ₹494.10 | -2.53% | 2,855 |
- Stock Market
- Stocks
- CORALAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
